Bionano Genomics, Inc. SEC filings BNGO

Bionano Genomics, Inc. has 629 filings in SEC EDGAR's recent list, going back to Aug 31, 2007. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Bionano Genomics, Inc. SEC filings
Form Description Filed Period
424B3 Prospectus Nov 5, 2026 —
424B3 Prospectus Nov 5, 2026 —
S-3/A Filing Nov 2, 2026 —
S-1 Registration statement Oct 27, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Oct 19, 2026 —
8-K Current report
Regulation FD disclosure
Sep 14, 2026 Sep 14, 2026
4 Insider transaction Sep 9, 2026 Sep 4, 2026
4 Insider transaction Aug 21, 2026 Aug 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
3 Initial insider ownership Aug 5, 2026 Aug 3, 2026
3 Initial insider ownership Aug 5, 2026 Aug 3, 2026
3 Initial insider ownership Aug 5, 2026 Aug 3, 2026
3 Initial insider ownership Aug 5, 2026 Aug 3, 2026
3 Initial insider ownership Jul 30, 2026 Jul 20, 2026
8-K Current report
Other events
Jun 24, 2026 Jun 24, 2026
8-K Current report
Officer or director change
Jun 5, 2026 Jun 2, 2026
4 Insider transaction Jun 3, 2026 Jun 3, 2026
4 Insider transaction Jun 3, 2026 Jun 3, 2026
4 Insider transaction Jun 3, 2026 Jun 3, 2026
4 Insider transaction Jun 3, 2026 Jun 3, 2026
8-K Current report
Other events
May 28, 2026 May 28, 2026
4 Insider transaction May 14, 2026 May 14, 2026
4 Insider transaction May 14, 2026 May 14, 2026
4 Insider transaction May 14, 2026 May 14, 2026
4 Insider transaction May 14, 2026 May 14, 2026
4 Insider transaction May 14, 2026 May 14, 2026
8-K Current report
Shareholder vote results
May 14, 2026 May 14, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
S-3 Shelf registration May 8, 2026 —
8-K Current report
Officer or director change, Other events
May 6, 2026 May 5, 2026
ARS Annual report to shareholders Apr 2, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 2, 2026 —
DEF 14A Proxy statement Apr 2, 2026 Apr 1, 2026
S-8 Employee stock plan registration Mar 25, 2026 —
10-K Annual report Mar 23, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 23, 2026 Mar 23, 2026
4 Insider transaction Feb 18, 2026 Feb 17, 2026
4 Insider transaction Feb 18, 2026 Feb 17, 2026
4 Insider transaction Feb 18, 2026 Feb 17, 2026
4 Insider transaction Feb 18, 2026 Feb 17, 2026
4 Insider transaction Feb 18, 2026 Feb 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 13, 2025 —
424B5 Prospectus supplement Oct 17, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Sep 24, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Sep 22, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Sep 19, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Sep 18, 2025 —
8-K Current report
Material agreement, Other events
Sep 18, 2025 Sep 16, 2025
SCHEDULE 13G Ownership over 5% (passive) Sep 17, 2025 —
EFFECT Filing Sep 16, 2025 —
424B4 Prospectus Sep 16, 2025 —
4/A Form 4/a Sep 12, 2025 Sep 11, 2025
4 Insider transaction Sep 12, 2025 Sep 11, 2025
4 Insider transaction Sep 12, 2025 Sep 11, 2025
CORRESP Letter to the SEC Sep 11, 2025 —
CORRESP Letter to the SEC Sep 11, 2025 —
S-1 Registration statement Sep 11, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
UPLOAD Letter from the SEC Aug 1, 2025 —
DRS Filing Jul 30, 2025 —
8-K/A Amended current report
Shareholder vote results
Jun 18, 2025 Jun 10, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 12, 2025 Jun 11, 2025
4 Insider transaction Jun 3, 2025 Jun 3, 2025
4 Insider transaction Jun 3, 2025 Jun 3, 2025
4 Insider transaction Jun 3, 2025 Jun 3, 2025
4 Insider transaction Jun 3, 2025 Jun 3, 2025
4 Insider transaction Jun 3, 2025 Jun 3, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 11, 2025
PRE 14A Preliminary proxy statement Apr 18, 2025 Jun 11, 2025
424B5 Prospectus supplement Apr 2, 2025 —
S-8 Employee stock plan registration Apr 2, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
8-K Current report
Material agreement
Feb 21, 2025 Feb 21, 2025
424B5 Prospectus supplement Feb 21, 2025 —
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
4 Insider transaction Feb 19, 2025 Feb 15, 2025
8-K Current report
Agreement ended
Feb 10, 2025 Feb 4, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jan 27, 2025 Jan 24, 2025
8-K Current report
Shareholder vote results
Jan 16, 2025 Jan 15, 2025
424B3 Prospectus Jan 14, 2025 —
8-K Current report
Results of operations
Jan 13, 2025 Jan 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Jan 13, 2025 —
EFFECT Filing Jan 10, 2025 —
CORRESP Letter to the SEC Jan 8, 2025 —
S-3/A Filing Jan 8, 2025 —
UPLOAD Letter from the SEC Jan 8, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Jan 6, 2025 Jan 3, 2025
424B5 Prospectus supplement Jan 6, 2025 —
S-3 Shelf registration Jan 3, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 3, 2025 Dec 31, 2024
DEFA14A Additional proxy material Dec 19, 2024 —
DEFA14A Additional proxy material Dec 5, 2024 —
DEF 14A Proxy statement Dec 5, 2024 Jan 15, 2025
8-K Current report
Shareholder vote results
Dec 2, 2024 Nov 27, 2024
PRE 14A Preliminary proxy statement Nov 25, 2024 Jan 15, 2025
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Oct 31, 2024 Oct 30, 2024
424B5 Prospectus supplement Oct 31, 2024 —
DEFA14A Additional proxy material Oct 31, 2024 —
8-K Current report
Results of operations
Oct 10, 2024 Oct 10, 2024
DEFA14A Additional proxy material Oct 3, 2024 —
4 Insider transaction Oct 2, 2024 Oct 1, 2024
3 Initial insider ownership Sep 30, 2024 Sep 18, 2024
4 Insider transaction Sep 13, 2024 Sep 11, 2024
4 Insider transaction Sep 13, 2024 Sep 11, 2024
8-K Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
Sep 9, 2024 Sep 4, 2024
DEFA14A Additional proxy material Aug 21, 2024 —
DEF 14A Proxy statement Aug 21, 2024 Oct 2, 2024
EFFECT Filing Aug 12, 2024 —
424B3 Prospectus Aug 12, 2024 —
PRE 14A Preliminary proxy statement Aug 9, 2024 Oct 2, 2024
CORRESP Letter to the SEC Aug 8, 2024 —
UPLOAD Letter from the SEC Aug 7, 2024 —
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
S-3 Shelf registration Jul 31, 2024 —
8-K Current report
Listing notice
Jul 18, 2024 Jul 12, 2024
D Filing Jul 10, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Jul 8, 2024 Jul 4, 2024
424B5 Prospectus supplement Jul 8, 2024 —
8-K Current report
Shareholder vote results
Jun 21, 2024 Jun 18, 2024
EFFECT Filing Jun 20, 2024 —
424B3 Prospectus Jun 20, 2024 —
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
4 Insider transaction Jun 20, 2024 Jun 18, 2024
CORRESP Letter to the SEC Jun 17, 2024 —
UPLOAD Letter from the SEC Jun 14, 2024 —
S-3 Shelf registration Jun 10, 2024 —
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
D Filing Jun 5, 2024 —
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Regulation FD disclosure, Other events
May 28, 2024 May 23, 2024
S-8 Employee stock plan registration May 8, 2024 —
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Results of operations, Exit or restructuring costs
May 8, 2024 May 8, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 18, 2024
8-K Current report
Other events
Apr 8, 2024 Apr 8, 2024
424B5 Prospectus supplement Apr 8, 2024 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 5, 2024 Apr 4, 2024
ARS Annual report to shareholders Mar 6, 2024 Dec 31, 2023
4 Insider transaction Mar 5, 2024 Feb 15, 2024
4 Insider transaction Mar 5, 2024 Feb 15, 2024
4 Insider transaction Mar 5, 2024 Feb 15, 2024
4 Insider transaction Mar 5, 2024 Feb 15, 2024
10-K Annual report Mar 5, 2024 Dec 31, 2023
8-K Current report
Results of operations, Exit or restructuring costs
Mar 5, 2024 Mar 1, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Feb 28, 2024 Feb 27, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
BNGO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1411690
Former names
BioNano Genomics, Inc (until Oct 20, 2021); Bionano Genomics, Inc (until Oct 20, 2021); BioNanomatrix Inc (until Mar 24, 2011)

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.